US Stock MarketDetailed Quotes

ACGN Aceragen

Watchlist
  • 0.385
  • 0.0000.00%
Close Aug 22 16:00 ET
3.24MMarket Cap-0.04P/E (TTM)

About Aceragen Company

Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.

Company Profile

SymbolACGN
Company NameAceragen
CEOMr. John C. Taylor
MarketNASDAQ
Employees26
Fiscal Year Ends12-31
Websitehttps://www.aceragen.com

Company Executives

  • Name
  • Position
  • Salary
  • John C. Taylor
  • Chief Financial Officer, Chief Executive Officer, President and Director
  • 221.19K
  • Andy Jordan
  • Chief Strategy Officer
  • --
  • Daniel Salain
  • Chief Operating Officer
  • --
  • Carl N. Kraus
  • Chief Medical Officer
  • --
  • Vincent J. Milano
  • Chairman of the Board
  • 1.43M
  • Dr. Maxine Gowen,PhD
  • Independent Director
  • 66.24K
  • Ronald Wooten H.C.A.
  • Independent Director
  • 11.88K
  • Michael R. Dougherty
  • Independent Director
  • 89.43K
  • Dr. Cristina Csimma, Pharm.D.
  • Independent Director
  • 60.12K
Heat List
US
Overall
Symbol
Price
% Chg

No Data